American International Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-43,119
| Closed | -$766K | – | 3111 |
|
|
2018
Q3 | $766K | Buy |
43,119
+778
| +2% | +$13.4K | ﹤0.01% | 1617 |
|
|
2018
Q2 | $584K | Buy |
+42,341
| New | +$502K | ﹤0.01% | 1728 |
|
|
2017
Q2 | – | Sell |
-23,410
| Closed | -$60K | – | 3161 |
|
|
2017
Q1 | $60K | Buy |
23,410
+1,558
| +7% | +$3.6K | ﹤0.01% | 2786 |
|
|
2016
Q4 | $56K | Sell |
21,852
-57
| -0.3% | -$164 | ﹤0.01% | 2831 |
|
|
2016
Q3 | $67.7K | Buy |
21,909
+33
| +0.2% | +$103 | ﹤0.01% | 2810 |
|
|
2016
Q2 | $70.2K | Sell |
21,876
-110
| -0.5% | -$403 | ﹤0.01% | 2828 |
|
|
2016
Q1 | $68K | Hold |
21,986
| – | – | ﹤0.01% | 3696 |
|
|
2015
Q4 | $88K | Sell |
21,986
-38
| -0.2% | -$175 | ﹤0.01% | 3577 |
|
|
2015
Q3 | $101K | Buy |
22,024
+26
| +0.1% | +$136 | ﹤0.01% | 3477 |
|
|
2015
Q2 | $114K | Sell |
21,998
-1,310
| -6% | -$7.86K | ﹤0.01% | 3565 |
|
|
2015
Q1 | $146K | Hold |
23,308
| – | – | ﹤0.01% | 3244 |
|
|
2014
Q4 | $147K | Sell |
23,308
-922
| -4% | -$5.62K | ﹤0.01% | 3225 |
|
|
2014
Q3 | $147K | Sell |
24,230
-18
| -0.1% | -$123 | ﹤0.01% | 3223 |
|
|
2014
Q2 | $160K | Buy |
24,248
+3,531
| +17% | +$39.8K | ﹤0.01% | 3198 |
|
|
2014
Q1 | $493K | Buy |
20,717
+497
| +2% | +$7.21K | ﹤0.01% | 2099 |
|
|
2013
Q4 | $216K | Sell |
20,220
-203
| -1% | -$2.24K | ﹤0.01% | 2709 |
|
|
2013
Q3 | $272K | Buy |
20,423
+35
| +0.2% | +$553 | ﹤0.01% | 2449 |
|
|
2013
Q2 | $268K | Buy |
+20,388
| New | +$275K | ﹤0.01% | 2331 |
|
Other funds holding ECYT
American International Group's ECYT Position: Q4 2018 in Review
American International Group sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 43,119 shares — an estimated $766K sold.
American International Group first reported a position in ECYT in Q2 2013 and held it in 18 quarters. The position peaked at $766K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- American International Group reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- American International Group sold 43,119 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $766K.
- American International Group first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
- American International Group's Endocyte, Inc. Common Stock position peaked at $766K in Q3 2018.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on American International Group's 13F filing for Q4 2018, filed 13 Feb 2019.